insights_auto
Outlook: 8.3% bullish·25.0% bearish
Go to analysischevron_right
PHAT:NASDAQ
Phathom Pharmaceuticals Inc
$5.99
arrow_upward
+0.84%(+0.050) 1D
$5.99
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 27, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 8 analysts giving stock ratings to PHAT in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for PHAT in the last 3 months.
Highest
Current $5.99
$26.00 (+334.06%)
Average
$18.57 (+210.02%)
Lowest
$10.00 (+66.94%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Kristen Kluska Cantor Fitzgerald | Buy | Maintained | - | - | 10/23/2026 |
Chase Knickerbocker Craig-Hallum | Buy | Maintained | $15.00 | +150.4% | 10/21/2026 |
Matthew Caufield H.C. Wainwright | Buy | Maintained | $26.00 | +334.1% | 09/21/2026 |
Daniel Clark Leerink Partners | Hold | Initiated | $10.00 | +66.9% | 09/09/2026 |
Jenna Davidner Barclays | Buy | Maintained | $14.00 | +133.7% | 08/17/2026 |
Martin Auster Raymond James | Buy | Maintained | $21.00 | +250.6% | 07/31/2026 |
Yatin Suneja Guggenheim | Buy | Maintained | $22.00 | +267.3% | 07/31/2026 |
Joseph Stringer Needham | Buy | Maintained | $22.00 | +267.3% | 07/30/2026 |
Paul Choi Goldman Sachs | Hold | Maintained | - | - | 04/30/2026 |